Testing effectiveness (Phase 2)Active Not RecruitingNCT02171104
What this trial is testing
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Who this might be right for
Mucopolysaccharidosis DisordersHurler SyndromeHunter Syndrome+26 more
Masonic Cancer Center, University of Minnesota 149